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The myogenic basic helix-loop-helix transcription factor myogenin plays an essential role in the differentiation of skeletal
muscle and, secondarily, in rib and sternum formation during mouse development. However, virtually nothing is known
about the quantitative requirements for myogenin in these processes. Here, we describe the generation of mice carrying a
hypomorphic allele of myogenin, which expresses myogenin transcripts at approximately one-fourth the level of the
wild-type myogenin allele. The hypomorphic allele in combination with wild-type and myogenin-null alleles was used to
create an allelic series. Embryos representing the complete range of genotypes from homozygous wild type to homozygous
null were analyzed for their viability, ability to form normal ribs and sternum, and extent of skeletal muscle differentiation.
Embryos carrying the hypomorphic myogenin allele over a wild-type allele were normal. In embryos bearing homozygous
hypomorphic alleles, the sternum developed normally and extensive skeletal muscle differentiation occurred. However,
muscle hypoplasia and reduced muscle-specific gene expression were apparent in these embryos, and the mice were not
viable as neonates. When the hypomorphic allele was placed over a myogenin-null allele, the resulting embryos had sternum
defects resembling homozygous myogenin-null embryos, and there was severe muscle hypoplasia. Our results demonstrate
that skeletal muscle formation is highly sensitive to the absolute levels of myogenin and that correct sternum formation,
skeletal muscle differentiation, and viability each require distinct threshold levels of myogenin. © 1999 Academic PressKey Words: skeletal muscle differentiation; myogenin; muscle-specific gene expression; bHLH proteins.
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Terminal differentiation of skeletal muscle in the mouse
is under the control of the muscle-specific basic-helix-loop-
helix (bHLH) transcription factor myogenin (for reviews,
see Arnold and Braun, 1996; Yun and Wold, 1996). In mice
lacking a functional myogenin gene, myoblasts form and
migrate to their correct embryonic locations, but most do
not fuse; the mice die at birth due to a severe deficiency of
myofibers (Hasty et al., 1993; Nabeshima et al., 1993;
enuti et al., 1995). While myogenin is known to play a role
in activation of many muscle-specific genes (reviewed by
Arnold and Braun, 1993; Olson, 1990), it is not clear why
the loss of myogenin should have such a dramatic effect onp
r1 To whom correspondence should be addressed.
44uscle formation since two other closely related myogenic
HLH factors, Myf5 and MyoD, are expressed at normal
evels in myogenin-null mice (Hasty et al., 1993; Rawls et
l., 1995). Myf5 and MyoD, however, fail to compensate for
yogenin’s absence. Thus, myogenin has acquired a unique
unction in the myogenic differentiation pathway and can
ctivate sets of genes that are not activated by Myf5 or
yoD. Gene disruptions of myf5 and myoD implicate these
enes in a genetic hierarchy upstream of myogenin, where
hey play redundant roles in myoblast specification (Braun
t al., 1992; Rudnicki et al., 1992, 1993).
Analysis of knockout mice has revealed that in addition
o their roles in muscle development, the myogenic bHLH
actors play unexpected roles in skeleton formation. In
articular, myf5-, MRF4-, and myogenin-null mice all have
ib and sternum defects of differing severity (Braun et al.,
0012-1606/99 $30.00
Copyright © 1999 by Academic Press
All rights of reproduction in any form reserved.
a
c
i
s
m
t
a
o
a
d
e
a
o
h
1
m
1
1
g
a
p
1
t
R
a
a
t
m
s
d
t
r
e
f
a
t
g
e
a
c
d
f
b
t
D
45Hypomorphic Allele of Myogenin1992; Hasty et al., 1993; Nabeshima et al., 1993; Olson et
l., 1996). Because none of these factors is expressed in
artilage or cartilage precursors, these defects must be
ndirect; perhaps they are due to the absence of factors
ecreted from the myotome that are necessary for develop-
ent of the rib and sternum lineages and are dependent on
he myogenic bHLH proteins for their expression (Grass et
l., 1996).
Eliminating myogenin also affects the total cellular level
f the myogenic bHLH factors, and alterations in the
mount of one or more of these factors have the potential to
isturb protein–protein and protein–DNA interactions nec-
ssary for normal skeletal muscle gene expression (see Yun
nd Wold, 1996). Heterozygous mice harboring null alleles
f the four myogenic factors appear normal, indicating that
aploinsufficiency does not occur at these loci (Braun et al.,
992; Rudnicki et al., 1992; Hasty et al., 1993; Nabeshima
et al., 1993). Even so, there is very little information on the
quantitative requirements for the myogenic factors in
muscle differentiation in vivo.
The myogenin-null mice afford the opportunity to ad-
dress the quantitative aspects of myogenin’s function in
skeletal muscle differentiation and, secondarily, in rib/
sternum formation. How sensitive are these processes to
the absolute levels of myogenin? Mice heterozygous for the
myogenin-null allele have 50% of the level of myogenin
protein as homozygous wild-type mice, yet the mutation
does not produce any discernible change in phenotype
(Hasty et al., 1993). Thus, the level of myogenin necessary
to support skeletal muscle differentiation is between 0 and
50% of the homozygous wild-type level. We reasoned that if
hypomorphic alleles could be generated that express myo-
genin at levels below that of the wild-type myogenin allele
but above that of a null, an allelic series could be estab-
lished in which myogenin levels would vary over the
critical range.
During the course of experiments designed to “knock-in”
cDNAs encoding various myogenic bHLH factors at the
myogenin locus by homologous recombination in embry-
onic stem (ES) cells, we fortuitously generated a hypomor-
phic allele of myogenin. The nature of the hypomorphism
was likely due to lowered expression by this locus, which
expressed myogenin transcripts in embryonic skeletal
muscle at 22% of the level of the wild-type allele. In this
report, we describe the phenotypes of mice harboring this
allele in a homozygous state or over the myogenin-wild-
type or myogenin-null alleles. By varying myogenin levels
over a narrow range, we established distinct threshold
levels necessary for correct sternum formation, skeletal
muscle differentiation, and viability. Our data indicate that
skeletal muscle formation is highly sensitive to the abso-
lute levels of myogenin and suggest that minor shifts in the
equilibrium of myogenin with associated factors and DNA
target sites can have profound effects on muscle differen-
tiation and skeleton formation.
Copyright © 1999 by Academic Press. All rightMATERIALS AND METHODS
Construction of a myogenin knock-in vector. To make a
generalized targeting construct with a deletion removing most of
the first exon of myogenin, two PCR products were made using the
ouse myogenin genomic clone as a template (Edmondson et al.,
992). The first product corresponded to base pairs (bp) 2771 to
47 with respect to the transcriptional start site of the myogenin
ene. The other corresponded to bp 1512 to 11102 and contained
portion of the 39 end of the first exon. Ligation of these two PCR
roducts resulted in a myogenin genomic clone lacking bp 148 to
511 of myogenin’s first exon. This deletion construct maintains
he transcriptional start site and splice donor of the first exon.
estriction sites were added within the deleted region via PCR to
id in cloning. The construct was digested with BsmBI and SphI
nd, to provide arms of homology for recombination, cloned into
he BsmBI/SphI digested EcoRI genomic clone of myogenin (Ed-
ondson et al., 1992) in pBluescript. The SV40 T polyadenylation
ignal and pgkneo expression cassette were placed within this
eletion. The SV40 T tag was derived from a short PCR fragment of
he SV40 T 39 region corresponding to bp 11981 to 12625 with
espect to the transcriptional start site of SV40 T. The pgkneo
xpression cassette flanked by loxP sites (ploxPneo-1, obtained
rom J. Rossant) was cloned in the same transcriptional orientation
s the myogenin locus. A SrfI restriction site was placed on the 59
end of the SV40 polyadenylation tag so that we could clone cDNAs
into the targeting vector. An MC1TK cassette (McMahon and
Bradley, 1990) was placed outside the region of homology on the 39
end of this construct. The finished vector was named TK-KIV.
A myogenin cDNA fragment corresponding to bp 12 to 11035
with respect to the transcription start site was placed into TK-KIV
via blunt cloning into the SrfI site. This fragment contained the
entire coding region of myogenin but lacked the polyadenylation
signal. The myogenin cDNA placed into TK-KIV was sequenced
prior to electroporation into ES cells to assure the reading frame
was unaltered. This construct (TK-KIV-y) was linearized with KpnI
for electroporation into ES cells (Fig. 1).
Generation of ES cells and mice harboring the y allele and
genetic backgrounds of y allele-containing mice. The TK-KIV-y
targeting vector was linearized and electroporated into AB1 ES cells
(McMahon and Bradley, 1990). Electroporated cells were grown
under selection using G418 and FIAU (Hasty et al., 1993). Properly
argeted clones were identified by Southern hybridization of ES cell
enomic DNA. DNA digested with XbaI was probed with a
32P-labeled 500-bp EcoRI fragment of the myogenin cDNA. This 39
xternal probe detected an 11.2-kb wild-type allele and a 9.3-kb y
llele.
Properly targeted ES cells were injected into E3.5 albino blasto-
ysts, transferred to pseudopregnant mothers, and allowed to
evelop to term. Chimeras were mated with wild-type C57BL/6
emales, and the success of germline transmission was determined
y coat color of the offspring. Mice carrying the y allele transmitted
hrough the germline were identified by Southern analysis from tail
NA.
The myogenin-null allele (Hasty et al., 1993) was maintained in
either a 129/C57BL/6 mixed background or a congenic C57BL/6
background.
Embryos from the indicated time points were isolated from 1/y
intercrosses to obtain y/y embryos, 1/y crossed with 1/2 to obtain
y/2 embryos, and 1/2 crossed with 1/2 to obtain 2/2 embryos.
Embryos were genotyped by Southern hybridization analysis of
s of reproduction in any form reserved.
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46 Vivian et al.DNA derived from tail or yolk-sac DNA prepared as described by
Venuti et al. (1995).
Northern analysis. Total RNA was isolated from embryos at
E11.5 and E18.5 by guanidine denaturation and phenol extraction
(Chomczynski and Sacchi, 1987). Fifteen micrograms of total RNA
was used for Northern analysis. The probe used to detect both
endogenous and transgenic myogenin transcripts was a 900-bp
SacI/EcoRI fragment from the mouse myogenin cDNA. This probe
detected a 1.8-kb y-derived transcript, whereas the wild-type tran-
script was 1.5 kb. Normalization for loading was performed using
an S26 probe (Vincent et al., 1993). Quantification was performed
y phosphoimager scan.
Histology and immunohistochemistry. Tongues and ribcages
ith diaphragms were fixed overnight in 3.7% paraformaldehyde in
BS and then dehydrated and embedded in paraffin (Venuti et al.,
995). Sections of 8 mm thickness were placed onto Superfrost-
oated slides (Fisher) and rehydrated in PBS. The sections were
FIG. 1. Targeting of myogenin cDNA to endogenous myogenin lo
shown, and the protein-coding region is shaded. Arms of homolo
Southern analysis is shown. (B) Targeting vector. The targeting vec
1.8- and 1.6-kb arms of homology (bold). The deletion maintains the
contains the protein-coding region and a heterologous polyadenylat
by loxP elements is present downstream of the cDNA for positive se
of homology for selection against random integration events. (C) D
doubly resistant ES cell clones was isolated, digested with XbaI, an
kb; the targeted y band is 9.2 kb. X, XbaI.tained with a monoclonal antibody specific to the fast isoform of
yosin heavy chain (MY32, Sigma) at a titer of 1:400 and stained
Copyright © 1999 by Academic Press. All rightith horseradish peroxidase-conjugated secondary antibody ac-
ording to manufacturer’s instructions (Zymed).
For bone and cartilage staining, E18.5 embryos were removed
rom the mother, skinned, and eviscerated. Ribcages were stained
ith Alizarin red and Alcian blue as described by McLeod (1980).
RT-PCR. Tongues were dissected from E18.5 embryos, and
otal RNA was isolated by guanidine denaturation and phenol
xtraction (Chomczynski and Sacchi, 1987). Reverse transcription
f 1 mg of total RNA and subsequent PCR amplification were
performed essentially as described by Rawls et al. (1995). Primers
used for this analysis were MCK (Myer et al., 1997), MRF4, MHC,
MyoD (Patapoutian et al., 1995), and L7 (Hollenberg et al., 1993),
using the PCR cycle parameters as described therein. Control PCRs
without prior reverse transcription showed no product (data not
shown). Additionally, the following primers were used to detect
MEF2C transcripts: CAG TTA CCA TCC CAG TGT CC (upper)
and GGC TTA CGA TTA TTC ATT CC (lower). PCR amplifica-
(A) Endogenous myogenin locus. The three exons of myogenin are
f the targeting vector are in bold. The 39 external probe used in
ntains a deletion of most of the first exon of myogenin flanked by
scriptional start site. A myogenin cDNA placed within the deletion
gnal derived from the SV40 T transcript. A pgkneo cassette flanked
on. An MC1TK cassette is present at the 39 end outside of the arms
ion of targeted ES cells via Southern analysis. Genomic DNA from
bed with the 39 external probe. The detected wild-type band is 11.3cus.
gy o
tor co
tran
ion si
lecti
etect
d protion using these MEF2C primers was performed at 26 cycles and
resulted in a 327-bp fragment. Quantification was performed by
s of reproduction in any form reserved.
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47Hypomorphic Allele of Myogeninphosphoimager scans using PCR within the linear range of ampli-
fication relative to RNA input.
RESULTS
Generation of Mice Carrying a Hypomorphic
Allele of Myogenin
To knock-in cDNA sequences at the myogenin locus, we
created the TK-KI vector where the first exon of myogenin
was interrupted with sequences containing multiple clon-
ing and SV40 polyadenylation sites and a pgkneo cassette,
which confers resistance to G418 (Figs. 1A and 1B). The neo
cassette was inserted in the same transcriptional orienta-
tion with respect to the myogenin gene and was used for
positive selection. The vector also included a TK gene for
negative selection; it was inserted at the truncated end of
the third exon of myogenin (Figs. 1A and 1B). A cDNA
ncoding the entire wild-type amino acid sequence of
yogenin was inserted into the multiple cloning site to
reate the final knock-in construct, TK-KIV-y (Fig. 1B). ES
TABLE 1
Summary of y Allele Breeding
Crossa
Time point of
genotyping
Number of
litters 1
/y X 1/y P10 8 1
E18.5 8 1
/y X 1/2 P10 5
E18.5 4
a Indicated crosses were performed and the resulting litters were
ABLE 2
henotypes of y Allele Mice
Myogenin
genotype
Neonatal
survival
Gross
morphology
Myoge
transc
level (
1/1 Viable Normal 100
1/y Viable Normal 726
1/2 Viable Normal 50
y/y Lethal Edemic, kyphosis 236
y/2 Lethal Edemic, kyphosis 166
2/2 Lethal Edemic, kyphosis 0a Myogenin transcript levels were quantified by phosphoimager sca
ormalization to an S26 control band.
Copyright © 1999 by Academic Press. All rightells were electroporated with this construct, and those
ells containing a homologous recombination event as
ssessed by Southern analysis (Fig. 1C) were injected into
lastocysts to generate chimeric mice. We will refer the
yogenin allele targeted with TK-KIV-y as the y allele (of
yogenin) for the remainder of the text.
One chimeric mouse produced viable and fertile offspring
with the genotype 1/y, and these offspring were used for
further breeding. Intercrosses of 1/y mice produced no
viable y/y offspring, indicating that the y allele was not
fully functional (Table 1). Inspection of embryos at E18.5
from 1/y females mated to 1/y males showed that while
1/y embryos had a normal gross morphology, y/y embryos
were swollen, had curved spines, and looked very much like
myogenin-null embryos (Hasty et al., 1993; Nabeshima et
al., 1993; Table 2). We also bred 1/y mice with mice that
were heterozygous for the myogenin-null allele (1/2). Only
offspring with 1/1, 1/y, or 1/2 genotypes were viable
(Table 1). Inspection of E18.5 embryos from these breedings
showed that y/2 embryos were grossly similar to 2/2
embryos (Table 2).
Genotype
1/y 1/2 y/y y/2 Total
29 — 0 — 43
25 — 13 — 48
7 9 — 0 24
5 4 — 6 17
otyped at either 10 days after birth (P10) or at E18.5.
Sternebrae
Skeletal
muscle
Muscle-
specific gene
expression
Normal Normal Normal
Normal Normal Normal
Normal Normal Normal
Normal, shortened
longitudinally
Moderate
hypoplasia
Reduced
Fused Severe
hypoplasia
nd
Fused; medial split;
no ossification
Severe
hypoplasia
Severely
reduced/1
4
0
8
2nin
ript
%)a
4
3
4nning of Northern blots standardizing each myogenin band by
s of reproduction in any form reserved.
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48 Vivian et al.These results were unexpected because the y allele
should have been capable of expressing a transcript that
could translate a full-length myogenin protein. When a lacZ
gene was inserted into the myogenin locus using the TK-KI
ector, the resulting chimeric embryos expressed lacZ
exclusively in developing somites and skeletal muscle (data
not shown), indicating that the temporal and spatial cis-
regulatory elements associated with the myogenin locus
ere intact. However, lacZ expression was relatively weak,
uggesting that expression from the y allele might also be
ttenuated relative to the wild-type myogenin allele. To
nvestigate expression from the y allele, we took advantage
f the predicted size difference between wild-type (1.5 kb)
nd y transcripts (1.8 kb). Northern analysis using RNA
xtracted from 1/y embryos at E11.5 or E18.5 and hybrid-
zed with a myogenin coding sequence probe showed the
xpected size for y and wild-type transcripts (Fig. 2A).
owever, at either embryonic stage, the y transcript was
nly 22% of the level of the wild-type transcript in a y/1
genotype. To determine the transcript levels in y/y and y/2
enotypes, Northern analysis was performed on RNA from
18.5 embryos with these genotypes (Fig. 2B). In addition to
etecting wild-type and y transcripts, the probe used in this
nalysis also hybridized to a 1.4-kb null-derived transcript
nown to be nonfunctional (Fig. 2B; Hasty et al., 1993). The
evels of y transcripts in y/y embryos were approximately
2% of the levels of myogenin wild-type transcripts in 1/1
mbryos. The levels of y transcripts in y/2 embryos were
approximately 16% of wild-type transcript levels. These
data were consistent with the expectation that the y allele
was equivalently expressed in all y allele-containing geno-
types (Fig. 2C). We conclude that the y allele expressed
myogenin transcripts at reduced levels relative to the wild-
type allele and that the lethality observed in y/y and y/2
embryos was most likely caused by insufficient levels of
myogenin transcript.
Sternum Formation in Embryos Containing
the y Allele
In our earlier analysis of myogenin-null mice, we de-
scribed an unexpected defect in the rib cage and sternum,
sites where myogenin is never expressed. In these null
ice, the ribs are shorter, abnormally curved, and mis-
ligned (Hasty et al., 1993; Fig. 3). In addition, the sternum
s shorter and excessively ossified and the cartilage between
he sternebrae being either reduced or absent (Hasty et al.,
993; compare Figs. 3A and 3D). Apparently rib growth or
FIG. 2. Myogenin expression from the y allele. (A, B) Northern an
corresponding to the coding region of myogenin was used to detect
Total RNA from whole embryos at E11.5 and E18.5. (B) Total RN
(Vincent et al., 1993). A nonfunctional null-derived transcript, det
amount of functional myogenin transcript in each genotype with the
transcript level in 1/y tissue.
Copyright © 1999 by Academic Press. All rightigration was abnormal in the mutant embryos and the
ailure of the ribs to attach to the sternum at the correct
ime led to ossification of the sternebrae, particularly at the
nterior. Other sternum phenotypes were seen in
yogenin-null embryos, including medial splitting of the
ternum (Fig. 3E) and lack of ossification of the sternebrae
Fig. 3F). The basis for variation in the sternum phenotype
n myogenin-null mice is not clear, but it cannot be
xplained by mixed genetic background effects, as each of
he described sternum phenotypes was seen in null em-
ryos in the congenic C57BL/6 background. In spite of the
ariation, all null embryos that we examined exhibited
ternum defects. We therefore asked whether the y allele of
yogenin could rescue the sternum defects observed in
yogenin-null embryos.
Skeletal preparations of littermates at E18.5 showed that
ternum of y/y embryos had normal regions of cartilage
etween sternebrae (Fig. 3B). The sternebrae, although
lightly shorter than wild-type sternebrae, displayed normal
ssification and morphology, similar to 1/1, 1/y, or 1/2
embryos (compare Fig. 3A and Fig. 3B). The ventral ribcage
protrusion, as seen in 2/2 embryos, however, was present
in y/y embryos (not shown). These results indicated that
expression from two copies of the y allele was sufficient to
overcome the sternum defects seen in myogenin-null mice.
In contrast, y/2 embryos exhibited defects similar to those
bserved in many 2/2 skeletal preparations (for example,
ompare Fig. 3C and Fig. 3D), indicating that insufficient
evels of myogenin were present in these embryos for proper
ternum formation. Although an exhaustive analysis was
ot performed, the only sternum phenotype seen in y/2
mbryos was sternebrae fusions; no split sternebrae or
onossified sternums were observed. The sternum pheno-
ype could thus be modulated by a single copy of the y allele
(Table 2). The dose-dependent phenotypic rescue of the
sternum defect by the y allele was strong evidence that this
allele was acting as a hypomorph with respect to sternum
formation.
Skeletal Muscle Formation in y/y and y/2 Embryos
Our previous characterization of myogenin-null mice
showed a dramatic reduction in the number of myofibers in
muscle masses of embryos and neonates and a correspond-
ingly excessive number of unfused myoblasts (Hasty et al.,
1993). Residual myofibers were always present in
myogenin-null embryos, indicating that some differentia-
tion can occur even in the absence of myogenin. The
is. Genotypes of each sample are shown above each lane. A probe
d-type 1.5-kb transcript and a y allele-derived 1.8-kb transcript. (A)
om carcasses at E18.5. S26 probe was used to control for loading
with this probe, is indicated. (C) Histogram comparing the totalalys
a wil
A fr
ectedamount of myogenin transcript predicted from extrapolation of y
s of reproduction in any form reserved.
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50 Vivian et al.number of residual myofibers varied with the muscle group
and genetic background, but tongue and diaphragm muscles
were particularly sensitive to the absence of myogenin. As
virtually no myofibers are present in these tissues, they
were chosen to evaluate the phenotypes associated with y/y
and y/2 mice.
Frontal sections of dissected intrinsic muscle of tongues
from E18.5 littermates were stained with an antibody
against MHC to reveal differentiated muscle fibers. As
described previously, tongues from 2/2 embryos were
essentially void of internal myofibers, although some myo-
fibers were found on the periphery (Fig. 4C). In contrast,
1/1, 1/2, and 1/y tongues contained a typical pattern of
densely packed longitudinal and transverse myofibers (Fig.
4A). Tongues from y/y embryos showed an intermediate
umber of myofibers, and the intensity of MHC staining
as significantly reduced from that of control tongues (Fig.
B). The highly ordered pattern of longitudinal and trans-
erse myofibers was disrupted in the y/y tongues, suggest-
ing that proper differentiation was required for normal
myotube patterning. More severe myofiber deficiency was
observed in tongues from y/2 embryos, although these still
ontained a few myofibers (data not shown); in contrast,
/2 tongues contained virtually none.
Saggital sections of diaphragms from late-stage embryos
howed a similar effect. Diaphragms from 1/1, 1/y, or 1/2
mbryos sectioned in this manner and stained with MHC
ntibody showed numerous myofibers in cross-section (Fig.
A). Fewer fibers were seen in y/y diaphragms, although
xtensive differentiation had obviously occurred in com-
arison to 2/2 controls, in which no myofibers were
etected (Fig. 5B versus Fig. 5D). Myofibers in y/y dia-
phragms had the same diameter in cross-section as myofi-
bers in wild-type diaphragms. As with tongue preparations,
y/2 diaphragms had severe muscle hypoplasia but they still
retained a few myofibers; diaphragms from 2/2 embryos
did not (Fig. 5C). Thus, increased dosages of the y allele led
to increased numbers of myofibers in both tongue and
diaphragm (Table 2). Although analyses of muscle masses
from other regions of the embryo were complicated by the
presence of residual fibers, it was clear that more myofibers
were present in limb, intercostal, and back muscles of y/y
embryos than in these muscles of their 2/2 littermates
(data not shown). Thus, skeletal muscle phenotypes seen in
y/2 and y/y mice were intermediate between wild-type and
FIG. 3. Sternums in y allele embryos. Sternums from E18.5 embry
bone and cartilage, respectively. (A) 1/1. (B) y/y. (C) y/2, with s
showing split sternum. (F) 2/2, showing lack of ossification of ste
FIG. 4. MHC expression in frontal sections of tongue muscle from
sectioned, and stained with a monoclonal antibody against the fas
FIG. 5. MHC expression in diaphragm muscle of y allele embry
arasagittally, and stained with a monoclonal antibody against the fas
50 mm.
Copyright © 1999 by Academic Press. All rigmyogenin-null phenotypes, indicating that the y allele was
acting as a hypomorph.
To quantify the extent of muscle differentiation in y allele
embryos, we counted the number of myofibers in sectioned
diaphragms stained with MHC antibody (Fig. 6). The number
of myofibers in y/y diaphragms was approximately one-fifth
that found in diaphragms of embryos with 1/1, y/1, or 1/2
enotypes (Fig. 6). This extent of muscle differentiation in y/y
mbryos was not sufficient to support postnatal life. Reduc-
ng the y allele dose by one-half, from y/y to y/2, led to
ne-sixth the number of myofibers (Fig. 6). These results
emonstrated a nonlinear response to myogenin levels for the
rocess of skeletal muscle differentiation. The results also
uggested that a narrow threshold level of myogenin expres-
ion, somewhere between 22% (y/y) and 50% (1/2) levels,
as required for normal skeletal muscle differentiation to
ccur.
Expression of Muscle-Specific Genes in y/y Embryos
Using RT-PCR, we asked whether the expression of
muscle-specific genes correlated with the effects that were
observed by immunohistochemical analysis. In earlier inves-
tigations, we demonstrated that MCK, MHC, and MRF4 were
expressed at very low levels in 2/2 embryos and neonates,
while MyoD levels were unaffected (Rawls et al., 1995).
Expression levels of MCK, MHC, MEF2C, and MRF4 in
tongues isolated from y/y embryos at E18.5 were intermedi-
ate between 1/2 and 2/2 levels, whereas MyoD and L7
ribosomal protein RNA levels were the same with all geno-
types (Fig. 7A; Table 2). In Figs. 7B and 7C, the transcript
levels of MCK and MRF4 were normalized to those of MyoD
rather than L7 to adjust for equal muscle mass. Transcript
levels of MCK and MRF4 in y/2 muscle were close to
myogenin-null levels (Figs. 7B and 7C). These results demon-
strated that a reduction in the expression of myogenin
produced a corresponding decrease in the expression of
muscle-specific genes.
DISCUSSION
By creating an allele of myogenin that was expressed at
levels between those of the wild-type and null alleles, we
have been able to assess the effect of small changes in
concentration on myogenin’s function in skeletal muscle
were isolated and stained with Alizarin red and Alcian blue to stain
num fusions. (D) 2/2, showing anterior sternum fusions. (E) 2/2,
ebrae. Bar, 1 mm.
llele embryos. Tongues from E18.5 embryos were paraffin embedded,
oform of MHC. (A) Wild type, (B) y/y, and (C) 2/2. Bar, 100 mm.
. Ribcages from E18.5 embryos were paraffin embedded, sectionedos
ter
rn
y a
t is
ost isoform of MHC. (A) Wild-type, (B) y/y, (C) y/2, and (D) 2/2. Bar,
hts of reproduction in any form reserved.
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52 Vivian et al.differentiation and sternum formation. Our results show
that myogenin expression levels in y/y mice, which are
approximately half those in wild-type heterozygous mice
(1/2), are sufficient for normal sternum formation and
substantial muscle differentiation but cannot support post-
natal life. When myogenin expression levels are reduced to
half of y/y levels, as in y/2 mice, severe muscle hypoplasia
and sternum abnormalities resembling those of the ho-
FIG. 6. Relationship between myogenin gene dose and myofiber
number in diaphragms of y allele embryos. Myogenin expression
levels for each genotype are estimated from Northern analyses.
Myofiber number was determined from MHC staining of E18.5
diaphragm muscle and normalized to wild-type levels.
FIG. 7. Expression of muscle-specific genes in y allele embryos.
xpression by RT-PCR. (A) RT-PCR products. (B and C) Histograms depi
ach genotype. The data are normalized to wild-type levels for MyoD a
Copyright © 1999 by Academic Press. All rightozygous myogenin-null phenotype are apparent. These
bservations demonstrate a nonlinear response between
yogenin levels and extent of skeletal muscle differentia-
ion and imply that a sharp threshold level exists, above
hich myogenin is fully functional and below which it
annot function or functions extremely ineffectively.
We have not determined why the y allele is expressed at
ower levels than the wild-type myogenin allele. The cause
f the attenuated expression appears to be upstream of
ranslation since myogenin protein is detectable in y/y
mbryos (unpublished results). One possibility is that ex-
ression from the neo cassette disrupts transcription from
he myogenin promoter. However, preliminary experi-
ents where the neo cassette bounded by loxP sites was
emoved by breeding to a mouse in which cre is ubiqui-
ously expressed did not increase viability (data not shown).
t is also possible that the absence of an intron in the
yogenin cDNA attenuated transcription or export from
he nucleus, leading to an unstable pre-mRNA. Whatever
he cause, it is clear that the simple insertion of a cDNA by
omologous recombination into the desired locus does not
uarantee normal levels of expression from that locus.
The observed y transcript levels seen in y/1, y/y, and y/2
mbryos demonstrated that expression from the y allele
as constant and independent of the myogenin genotype.
hus, lowering the levels of myogenin in this fashion did
ot result in reduced y allele expression. This suggests that
myogenin is not required for its own transcription and is
consistent with previous transgenic experiments in which a
lacZ reporter gene controlled by myogenin upstream regu-
RNA was isolated from E18.5 tongues and assayed for transcriptTotal
cting the amount of RT-PCR product of (B) MCK and (C) MRF4 for
nd L7.
s of reproduction in any form reserved.
53Hypomorphic Allele of Myogeninlatory elements showed normal reporter expression in
myogenin-null embryos (Cheng et al., 1995).
The sternums of y/y mice closely resembled wild-type
sternums, but defects were observed, including short sternum
length and shortened individual sternebrae. These defects
might be due to defective body wall muscle surrounding the
ribcage, which could alter ribcage morphology. The overall
morphology of the ribcage was abnormal in y/y embryos,
including a ventral protrusion of the ribcage, which resembled
the ribcages of myogenin-null mice. The sternum defects
associated with myogenin and myf5 knockout mice are be-
lieved to be the result of defective cartilage precursors of the
rib, most likely caused by cell nonautonomous events since
myogenin and myf5 are not expressed in cartilage cells or their
precursors (Hasty et al., 1993; Grass et al., 1996). Fate mapping
in the chick has shown that the distal portion of the rib
derives from the lateral dermomyotome (Kato and Aoyama,
1998). Thus, myogenin could potentially function to control
the normal development of this region of the embryo. How-
ever, our analysis of the sternum defects in myogenin-null
mice shows a variety of defects, including a lack of ossifica-
tion and medial splitting of the sternebrae, and it is unclear
how defective rib precursor development could give rise to
these phenotypes. The role of myogenin in sternum formation
may be more complicated than acting solely on somitically
derived rib precursors. In the chick, the sternum is found to be
derived from the somatopleural mesoderm (Chevallier, 1975)
and it is possible that myogenin has a role in the development
of cells derived from this region of the embryo.
Although there were fewer myofibers in the diaphragms
of y/y embryos than in wild-type embryos, the majority of
myofibers appeared to be morphologically normal and have
comparable thickness and length. However, as assessed by
immunostaining and RT-PCR, the myofibers in y/y mice do
not express muscle-specific products at the same levels as
those in wild-type embryos and so the systems to which
they contribute are not likely to be fully functional. The
levels of myogenin in y/y embryos appear to be sufficient
for some myofibers to achieve a morphologically mature
state, although partially differentiated myofibers may also
contribute to the myofiber population.
The results presented in this study can be compared to
our previous observations with genetic chimeras containing
mixtures of wild-type and myogenin-null myoblasts (Myer
et al., 1997). In chimeric embryos, participation of null
myoblasts in fusion and myofiber formation is enhanced in
the presence of wild-type myoblasts. In chimeras with a
high percentage of wild-type myoblasts, hybrid myofibers
appear normal, whereas chimeras with high percentages of
null myoblasts have abnormal myofibers and lowered
muscle-specific gene expression (Myer et al., 1997). Appar-
ently, as myogenin levels drop below some critical value,
individual myofibers begin to lose their integrity. Sufficient
levels of myogenin must be present in myoblasts of y/y
embryos to generate significant numbers of normal-
appearing myofibers.
Decreasing the gene dose of myogenin clearly causes
Copyright © 1999 by Academic Press. All rightprofound alterations in muscle differentiation, but at
present we cannot say precisely what events are affected
when myogenin levels are reduced. It is possible that
different genes dependent on myogenin for their expression
require different concentrations of myogenin for full acti-
vation. Because myogenin works as a transcription factor in
combination with ubiquitous bHLH factors such as
E-proteins (Olson, 1990) and in some cases with the MEF2
family of MADS-box transcription factors (Molkentin et al.,
1995; Molkentin and Olson, 1996), lowering myogenin
levels could affect critical interactions with these proteins
and perturb the expression of distinct sets of genes.
The studies of Jaenisch and co-workers (Wang et al., 1996;
Wang and Jaenisch, 1997), where a myogenin sequence was
knocked into the myf5 locus, are relevant to the results
presented here. The inserted copy of myogenin completely
rescued the severe rib defect and the delay in skeletal
muscle specification associated with the myf5-null muta-
tion (Wang et al., 1996). However, in a myoD-null back-
ground, the myogenin knock-in could not completely re-
store the function of myf5 as was evident from muscle
hypoplasia and perinatal lethality (Wang and Jaenisch,
1997). Most importantly, in a myogenin-null background,
their myogenin knock-in mice displayed the same pheno-
type as myogenin-null mice (Wang and Jaenisch, 1997).
Because myf5 is expressed earlier than myogenin, it is
possible that myogenin levels in these knock-in mice were
not high enough when myogenin was needed and so muscle
hypoplasia resulted. Our results support this view and
suggest that whenever myogenin levels are reduced below
50% of wild-type levels, skeletal muscle deficiency will
occur.
The hypomorphic myogenin allele may be useful in
identifying other factors associated with myogenin-
dependent muscle differentiation. Mutations in candidate
genes, in either the heterozygous or homozygous state, can
be crossed into the y/y hypomorphic background. Any
alteration of the hypomorphic phenotype would be evi-
dence that the candidate gene lies within a myogenin-
dependent skeletal muscle differentiation pathway. The
nonlinear response to low levels of myogenin (compare y/y
vs y/2 phenotypes) suggests that myogenin may regulate
the expression of either an essential cofactor or another
gene that functionally overlaps with myogenin. These
genes may be identifiable using the phenotypic test de-
scribed above. In particular, this technique may useful for
analyzing the function of the MEF2 transcription factors in
skeletal muscle development. Although there is ample
circumstantial evidence to suggest that these factors are
involved in skeletal muscle development (reviewed in
Molkentin and Olson, 1996), it has been difficult to analyze
these functions in vivo. For example, heterozygous MEF2C-
deficient mice are wild type, and homozygous MEF2C-
deficient mice die before skeletal muscle defects would
appear (Lin et al., 1997).While our results indicate that a critical level of myo-
genin is necessary for terminal muscle differentiation, they
s of reproduction in any form reserved.
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54 Vivian et al.do not address whether other myogenic bHLH factors, if
expressed at the appropriate levels, can replace myogenin’s
function. It has recently been shown that myogenin is not
the only myogenic bHLH factor needed for the terminal
differentiation steps of myogenesis (Rawls et al., 1998).
Neither myoD- nor MRF4-null mice exhibit major defects
n skeletal muscle differentiation, but a double knockout of
yoD and MRF4 produces a phenotype identical to that
een for myogenin-null mice (Rawls et al., 1998). Thus,
yoD and MRF4 have an overlapping function in muscle
ifferentiation for which myogenin cannot compensate.
urthermore, compound triple heterozygous mice with the
enotype myogenin (1/2), myoD (1/2), MRF4 (1/2) are
henotypically normal (R. Valdez and E. Olson, unpub-
ished results). Thus, in contrast to y/y embryos where a
0% reduction in expression had a clear effect on muscle
ifferentiation, halving the levels of the three myogenic
HLH factors in combination had no effect. This result,
lbeit negative, supports the view that myogenin’s role is
argely independent of the other myogenic bHLH factors.
nocking the genes for myoD, myf5, and MRF4 into the
yogenin locus with expression levels of the knock-in
lleles comparable to the wild-type myogenin allele should
rovide strong evidence for or against this hypothesis.
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